Format
Sort by
Items per page

Send to

Choose Destination

Best matches for endometrial carcinoma AND (free full text[sb] AND:

Improving oncologic outcomes for women with endometrial cancer: realigning our sights. Dowdy SC et al. Gynecol Oncol. (2014)

[Expression of pin1 in endometrial carcinoma and its relation with PR]. Tian Y et al. Nan Fang Yi Ke Da Xue Xue Bao. (2013)

Pathology of endometrioid carcinoma. Albertini AF et al. Bull Cancer. (2012)

Search results

Items: 1 to 20 of 6926

  • The following terms were ignored: (, AND
  • See the search details.
1.

Comparison of outcomes following laparoscopic and open hysterectomy with pelvic lymphadenectomy for early stage endometrial carcinoma.

Ruan XC, Wong WL, Yeong HQ, Lim YKT.

Singapore Med J. 2018 Jul;59(7):366-369. doi: 10.11622/smedj.2018088.

2.

Upregulation of miR-582-5p regulates cell proliferation and apoptosis by targeting AKT3 in human endometrial carcinoma.

Li L, Ma L.

Saudi J Biol Sci. 2018 Jul;25(5):965-970. doi: 10.1016/j.sjbs.2018.03.007. Epub 2018 Mar 10.

3.

Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late.

Remmerie M, Janssens V.

Int J Mol Sci. 2018 Aug 13;19(8). pii: E2380. doi: 10.3390/ijms19082380. Review.

4.

Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens.

Tetikkurt S, Çelik E, Taş H, Cay T, Işik S, Usta AT.

Mol Clin Oncol. 2018 Aug;9(2):231-237. doi: 10.3892/mco.2018.1660. Epub 2018 Jun 18.

5.

The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics.

Yu L, Chen S, Bao H, Zhang W, Liao M, Liang Q, Cheng X.

Onco Targets Ther. 2018 Jul 25;11:4355-4365. doi: 10.2147/OTT.S166132. eCollection 2018.

6.

A retrospective study of disease incidence in African pygmy hedgehogs (Atelerix albiventris).

Okada K, Kondo H, Sumi A, Kagawa Y.

J Vet Med Sci. 2018 Aug 7. doi: 10.1292/jvms.18-0238. [Epub ahead of print]

7.

Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.

Wortman BG, Bosse T, Nout RA, Lutgens LCHW, van der Steen-Banasik EM, Westerveld H, van den Berg H, Slot A, De Winter KAJ, Verhoeven-Adema KW, Smit VTHBM, Creutzberg CL; PORTEC Study Group.

Gynecol Oncol. 2018 Aug 2. pii: S0090-8258(18)31084-9. doi: 10.1016/j.ygyno.2018.07.020. [Epub ahead of print]

8.

Clear cell carcinoma of the pelvic side wall arising from endometriosis.

Abaid LN, Cupp JS, Chang M, Beanes SR, Goldstein BH.

Gynecol Oncol Rep. 2018 May 14;25:24-26. doi: 10.1016/j.gore.2018.05.006. eCollection 2018 Aug.

9.

Endometrial cancer with an EML4-ALK rearrangement.

Craig JW, Quade BJ, Muto MG, MacConaill LE.

Cold Spring Harb Mol Case Stud. 2018 Aug 1;4(4). pii: a003020. doi: 10.1101/mcs.a003020. Print 2018 Aug.

10.

Germline SDHA mutations in children and adults with cancer.

Dubard Gault M, Mandelker D, DeLair D, Stewart CR, Kemel Y, Sheehan MR, Siegel B, Kennedy J, Marcell V, Arnold A, Al-Ahmadie H, Modak S, Robson M, Shukla N, Roberts S, Vijai J, Topka S, Kentsis A, Cadoo K, Carlo M, Latham Schwark A, Reznik E, Dinatale R, Hechtman J, Borras Flores E, Jairam S, Yang C, Li Y, Bayraktar EC, Ceyhan-Birsoy O, Zhang L, Kohlman W, Schiffman J, Stadler Z, Birsoy K, Kung A, Offit K, Walsh MF.

Cold Spring Harb Mol Case Stud. 2018 Aug 1;4(4). pii: a002584. doi: 10.1101/mcs.a002584. Print 2018 Aug.

11.

Distribution-based measures of tumor heterogeneity are sensitive to mutation calling and lack strong clinical predictive power.

Noorbakhsh J, Kim H, Namburi S, Chuang JH.

Sci Rep. 2018 Jul 30;8(1):11445. doi: 10.1038/s41598-018-29154-7.

12.

Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers.

Suyama K, Iwase H.

Cancer Control. 2018 Jan-Dec;25(1):1073274818789361. doi: 10.1177/1073274818789361.

13.

Association Analysis between Body Mass Index and Genomic DNA Methylation across 15 Major Cancer Types.

Gu Y, Zhang CW, Wang L, Zhao Y, Wang H, Ye Q, Gao S.

J Cancer. 2018 Jun 22;9(14):2532-2542. doi: 10.7150/jca.23535. eCollection 2018.

14.

Clinical significance of matrix metalloproteinase-2 in endometrial cancer: A systematic review and meta-analysis.

Liu C, Li Y, Hu S, Chen Y, Gao L, Liu D, Guo H, Yang Y.

Medicine (Baltimore). 2018 Jul;97(29):e10994. doi: 10.1097/MD.0000000000010994. Review.

15.

Where do these guests come from? A diagnostic approach for metastatic lymph nodes.

Dere Y, Ekmekçi S, Çelik S, Çelik Öİ, Dere Ö, Karakuş V.

Turk J Surg. 2018 Jul 1;34(2):131-136. doi: 10.5152/turkjsurg.2018.3856. eCollection 2018.

16.

The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients.

Lim S, Kim YH, Lee KB, Lee JM.

J Gynecol Oncol. 2018 Sep;29(5):e72. doi: 10.3802/jgo.2018.29.e72. Epub 2018 May 4.

17.

Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.

Matsuo K, Machida H, Mariani A, Mandelbaum RS, Glaser GE, Gostout BS, Roman LD, Wright JD.

J Gynecol Oncol. 2018 Sep;29(5):e69. doi: 10.3802/jgo.2018.29.e69. Epub 2018 May 4.

18.

Case Report: Synchronous primary malignancy including the breast and endometrium.

Banimostafavi ES, Tayebi S, Tayebi M, Montazer F.

Version 3. F1000Res. 2017 Aug 17 [revised 2018 Jan 1];6:1502. doi: 10.12688/f1000research.11971.3. eCollection 2017.

19.

Liposomal Curcumin Targeting Endometrial Cancer Through the NF-κB Pathway.

Xu H, Gong Z, Zhou S, Yang S, Wang D, Chen X, Wu J, Liu L, Zhong S, Zhao J, Tang J.

Cell Physiol Biochem. 2018 Jul 18;48(2):569-582. doi: 10.1159/000491886. [Epub ahead of print]

20.

Mitochondrial Dysfunctions in Type I Endometrial Carcinoma: Exploring Their Role in Oncogenesis and Tumor Progression.

Musicco C, Cormio G, Pesce V, Loizzi V, Cicinelli E, Resta L, Ranieri G, Cormio A.

Int J Mol Sci. 2018 Jul 17;19(7). pii: E2076. doi: 10.3390/ijms19072076. Review.

Supplemental Content

Loading ...
Support Center